Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4021152
Disease: Abnormal CNS myelination
Abnormal CNS myelination
0.100 Biomarker disease HPO
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.010 GeneticVariation group BEFREE Plasma DNA samples from 73 patients with stage IIIB to IV adenocarcinoma were analyzed for EGFR mutations in exons 19 (deletion mutation) and 21 (L858R mutation) using direct DNA sequencing, DHPLC and Scorpions ARMS. 21518597 2011
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder)
0.010 GeneticVariation disease BEFREE ARMS for EGFR mutation analysis of cytologic and corresponding lung adenocarcinoma histologic specimens. 25156817 2015
CUI: C0032580
Disease: Adenomatous Polyposis Coli
Adenomatous Polyposis Coli
0.010 GeneticVariation disease BEFREE For all subjects, DNA was genotyped for APC I1307K and E1317Q polymorphisms using the PCR-ARMS technique. 26314409 2016
CUI: C0279550
Disease: Adult Rhabdomyosarcoma
Adult Rhabdomyosarcoma
0.020 Biomarker disease BEFREE These results indicate that berberine derivatives have the potential of anti-tumor drugs for RMS therapy.<b>Abbreviations</b>: ARMS: alveolar rhabdomyosarcoma; ERMS: embryonal rhabdomyosarcoma; RMS: rhabdomyosarcoma. 31462179 2020
CUI: C0279550
Disease: Adult Rhabdomyosarcoma
Adult Rhabdomyosarcoma
0.020 GeneticVariation disease BEFREE We observed that while both embryonal and alveolar rhabdomyosarcomas (ERMS and ARMS, respectively) show LOI of the DMR at the IGF2-H19 locus, imprinting of the DMR at the DLK1-GTL2 locus varies in association with the histological subtype of RMS. 24173021 2014
CUI: C0278660
Disease: Adult Synovial Sarcoma
Adult Synovial Sarcoma
0.010 GeneticVariation disease BEFREE Among the samples of ARMS, 50% had rearrangements of PAX3/7-FOXO1, 60% of ES samples were EWS-FLI1 positive and 90% of SS samples were positive for SS18-SSX1/2. 24846856 2014
CUI: C0242383
Disease: Age related macular degeneration
Age related macular degeneration
0.010 GeneticVariation disease BEFREE Association of Combined Complement Factor H Y402H and ARMS/LOC387715 A69S Polymorphisms with Age-related Macular Degeneration: A Meta-analysis. 27269047 2016
CUI: C0948201
Disease: Alloimmunisation
Alloimmunisation
0.010 GeneticVariation disease BEFREE Because new genes have recently been mapped within the MHC class II region, we typed TAP1 and TAP2 gene polymorphisms by ARMS-PCR in order to characterize more effectively MHC genes involved in this alloimmunization. 7860359 1994
CUI: C0206655
Disease: Alveolar rhabdomyosarcoma
Alveolar rhabdomyosarcoma
0.040 Biomarker disease BEFREE We observed that while both embryonal and alveolar rhabdomyosarcomas (ERMS and ARMS, respectively) show LOI of the DMR at the IGF2-H19 locus, imprinting of the DMR at the DLK1-GTL2 locus varies in association with the histological subtype of RMS. 24173021 2014
CUI: C0206655
Disease: Alveolar rhabdomyosarcoma
Alveolar rhabdomyosarcoma
0.040 Biomarker disease BEFREE A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma. 23432728 2013
CUI: C0206655
Disease: Alveolar rhabdomyosarcoma
Alveolar rhabdomyosarcoma
0.040 Biomarker disease BEFREE NGF/TrkA-mediated Kidins220/ARMS signaling activated in the allergic airway challenge in mice. 20934630 2010
CUI: C0206655
Disease: Alveolar rhabdomyosarcoma
Alveolar rhabdomyosarcoma
0.040 Biomarker disease BEFREE These results indicate that berberine derivatives have the potential of anti-tumor drugs for RMS therapy.<b>Abbreviations</b>: ARMS: alveolar rhabdomyosarcoma; ERMS: embryonal rhabdomyosarcoma; RMS: rhabdomyosarcoma. 31462179 2020
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.020 Biomarker disease BEFREE Unexpectedly, Kidins220 is augmented in necropsies from AD patients where it accumulates with hyperphosphorylated tau. 23118350 2013
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.020 Biomarker disease BEFREE This study highlights the potential of Kidins220 as a CSF biomarker in AD. 27858709 2017
CUI: C0004096
Disease: Asthma
Asthma
0.030 GeneticVariation disease BEFREE In all, 336 UK Caucasian families with > or = 2 affected sibs (physician's diagnosis of asthma and current medication use) and 179 Caucasians without asthma or a family history of asthma were genotyped using ARMS-PCR. 14735148 2004
CUI: C0004096
Disease: Asthma
Asthma
0.030 AlteredExpression disease BEFREE To investigate whether the downstream protein ankyrin-rich membrane spanning (ARMS), a novel transmembrane substrate of protein kinase D (Kidins220), is activated in the pathogenesis of asthma. 20934630 2010
CUI: C0004096
Disease: Asthma
Asthma
0.030 Biomarker disease BEFREE For this, 366 subjects (155 asthmatic and 211 normal control subject) were genotyped using Amplification Refractory Mutation System Analysis (ARMS-PCR) and agarose gel electrophoresis. 16393721 2005
CUI: C0004106
Disease: Astigmatism
Astigmatism
0.100 Biomarker disease HPO
CUI: C0041671
Disease: Attention Deficit Disorder
Attention Deficit Disorder
0.010 Biomarker disease BEFREE The subgroups significantly differed in important features, including specific working memory deficits for PTPRG (n=5); severe negative symptoms, global cognitive deficits and poor educational attainment, suggesting a developmental disorder, for SLC39A13 (n=4); slow processing speed, childhood attention deficit disorder and milder symptoms for TGM5 (n=4); and global cognitive deficits with good educational attainment suggesting neurodegeneration for ARMS/KIDINS220 (n=5). 27211562 2016
Attention deficit hyperactivity disorder
0.010 Biomarker disease BEFREE The subgroups significantly differed in important features, including specific working memory deficits for PTPRG (n=5); severe negative symptoms, global cognitive deficits and poor educational attainment, suggesting a developmental disorder, for SLC39A13 (n=4); slow processing speed, childhood attention deficit disorder and milder symptoms for TGM5 (n=4); and global cognitive deficits with good educational attainment suggesting neurodegeneration for ARMS/KIDINS220 (n=5). 27211562 2016
Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type
0.010 Biomarker disease BEFREE The subgroups significantly differed in important features, including specific working memory deficits for PTPRG (n=5); severe negative symptoms, global cognitive deficits and poor educational attainment, suggesting a developmental disorder, for SLC39A13 (n=4); slow processing speed, childhood attention deficit disorder and milder symptoms for TGM5 (n=4); and global cognitive deficits with good educational attainment suggesting neurodegeneration for ARMS/KIDINS220 (n=5). 27211562 2016
CUI: C0004943
Disease: Behcet Syndrome
Behcet Syndrome
0.030 GeneticVariation disease BEFREE The frequencies of three FMF-related MEFV mutations (M694V, M680I and V726A) were investigated in BD patients (n = 57) by molecular genetic studies using a polymerase chain reaction with the ARMS method. 14727457 2004
CUI: C0004943
Disease: Behcet Syndrome
Behcet Syndrome
0.030 GeneticVariation disease BEFREE We analyzed the association of NRAMP1 polymorphisms [(GT)( n ), INT4, 3'UTR and D543N] in 102 Turkish patients with BS and 102 healthy subjects by using amplification refractory mutation system-polymerase chain reaction (ARMS-PCR). 18998137 2009
CUI: C0004943
Disease: Behcet Syndrome
Behcet Syndrome
0.030 GeneticVariation disease BEFREE IL10 -1082G/A, -819C/T and -592C/A and TNF -308G/A polymorphisms were analyzed in 102 Turkish patients with BS and 102 healthy subjects by using amplification refractory mutation system-polymerase chain reaction (ARMS-PCR). 20191386 2010